Scarica l'app Stockscreener
3.85
3.27%
-0.13
Precedente Chiudi:
$3.98
Aprire:
$3.98
Volume 24 ore:
653.67K
Relative Volume:
1.01
Capitalizzazione di mercato:
$68.00M
Reddito:
-
Utile/perdita netta:
$-30.54M
Rapporto P/E:
-2.4839
EPS:
-1.55
Flusso di cassa netto:
$-18.30M
1 W Prestazione:
-4.70%
1M Prestazione:
-8.33%
6M Prestazione:
+498.66%
1 anno Prestazione:
+780.20%
Intervallo 1D:
$3.82
$4.06
Intervallo di 1 settimana:
$3.82
$4.14
Portata 52W:
$0.34
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
Nome
Unicycive Therapeutics Inc
Settore
Industria
Telefono
650-384-0642
Indirizzo
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Confronta UNCY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
3.85 | 70.29M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | Guggenheim | Buy |
| 2024-04-04 | Iniziato | Piper Sandler | Overweight |
Unicycive Therapeutics Inc Borsa (UNCY) Ultime notizie
UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Agains - GuruFocus
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - FinancialContent
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive - PR Newswire
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive - MarketScreener
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers – UNCY - GlobeNewswire Inc.
Is it too late to sell Unicycive Therapeutics Inc.New Guidance & AI Driven Stock Movement Reports - newser.com
Using AI based signals to follow Unicycive Therapeutics Inc.2025 Market WrapUp & Free Real-Time Market Sentiment Alerts - newser.com
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Lost Money on Unicycive Therapeutics, Inc.(UNCY)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - Barchart.com
What machine learning models say about Unicycive Therapeutics Inc.2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
Using data filters to optimize entry into Unicycive Therapeutics Inc.July 2025 Spike Watch & Weekly Top Performers Watchlists - newser.com
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, - GuruFocus
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - MarketScreener
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky to Join Class Action Before October 14, 2025 - ACCESS Newswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Eagle-Tribune
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
Investors in Unicycive Therapeutics, Inc. (UNCY): Protect Your RightsContact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
UNCY STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky Before October 14, 2025 to Join Class Action - ACCESS Newswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - GlobeNewswire
Real time breakdown of Unicycive Therapeutics Inc. stock performance2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Advanced analytics toolkit walkthrough for Unicycive Therapeutics Inc.Weekly Investment Recap & Stock Timing and Entry Methods - newser.com
Is Unicycive Therapeutics Inc stock risky to hold nowMarket Movers & Risk Managed Investment Signals - خودرو بانک
What institutional flow reveals about Unicycive Therapeutics Inc.CPI Data & Weekly Top Performers Watchlists - newser.com
Unicycive Therapeutics Inc. stock trend outlook and recovery path2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
Investors who lost money on Unicycive Therapeutics, - GlobeNewswire
Unicycive Therapeutics Inc. recovery potential after sell offEarnings Risk Summary & Weekly Watchlist for Consistent Profits - newser.com
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Before October 14, 2025Contact Levi & Korsinsky - ACCESS Newswire
Pattern recognition hints at Unicycive Therapeutics Inc. upsideEarnings Overview Report & Precise Buy Zone Tips - newser.com
Using Ichimoku Cloud for Unicycive Therapeutics Inc. technicalsPortfolio Update Summary & Safe Capital Growth Tips - newser.com
Market Fear: How does Unicycive Therapeutics Inc. score in quality rankings2025 Sector Review & Reliable Price Breakout Signals - خودرو بانک
Market Review: Why is Unicycive Therapeutics Inc stock going downEarnings Miss & Risk Managed Investment Strategies - خودرو بانک
Dow Update: Will Unicycive Therapeutics Inc outperform small cap indexes2025 Institutional Moves & Expert Curated Trade Setup Alerts - خودرو بانک
What data driven models say about Unicycive Therapeutics Inc.’s futureWeekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
Aug Breakouts: Is Unicycive Therapeutics Inc stock a falling knife or bargain buyJuly 2025 Update & Daily Chart Pattern Signal Reports - خودرو بانک
Class Action Lawsuit Filed Against Unicycive Therapeutics by Levi & Korsinsky Over Alleged Securities Violations - geneonline.com
Shareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) should contact Levi & Korsinsky about pending Class ActionUNCY - PR Newswire
What’s the recovery path for long term holders of Unicycive Therapeutics Inc.Share Buyback & AI Powered Market Entry Strategies - newser.com
Unicycive Therapeutics, Inc. (UNCY) LawsuitInvestors Urged to Contact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
Is Unicycive Therapeutics Inc. trending in predictive chart modelsJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Visualizing Unicycive Therapeutics Inc. stock with heatmapsJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
Applying Elliott Wave Theory to Unicycive Therapeutics Inc.Earnings Trend Report & Growth Focused Stock Reports - newser.com
Will Unicycive Therapeutics Inc benefit from current market trendsBreakout Watch & Weekly Sector Rotation Insights - خودرو بانک
Faruqi & Faruqi Reminds Unicycive Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 14, 2025UNCY - Morningstar
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Hastings Tribune
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
Shareholders of Unicycive Therapeutics, Inc. Should Contact - GlobeNewswire
Shareholders SueWallSt in New Class Action Against Unicycive Therapeutics, Inc.Act Now - Nasdaq
Unicycive Therapeutics Inc Azioni (UNCY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):